Insufficient scRNA-seq data for expression of IL19 at single-cell level.
Insufficient scRNA-seq data for expression of IL19 at tissue level.
Tissue | GTEx Coverage | GTEx Average TPM | GTEx Number of samples | TCGA Coverage | TCGA Average TPM | TCGA Number of samples |
---|---|---|---|---|---|---|
kidney | 72% | 21.16 | 64 / 89 | 0% | 0.01 | 2 / 901 |
lymph node | 0% | 0 | 0 / 0 | 52% | 2.28 | 15 / 29 |
spleen | 47% | 3.66 | 114 / 241 | 0% | 0 | 0 / 0 |
thymus | 41% | 9.15 | 265 / 653 | 1% | 0.03 | 7 / 605 |
stomach | 30% | 27.57 | 109 / 359 | 6% | 0.25 | 18 / 286 |
peripheral blood | 32% | 10.61 | 301 / 929 | 0% | 0 | 0 / 0 |
esophagus | 18% | 44.52 | 263 / 1445 | 14% | 0.67 | 25 / 183 |
uterus | 13% | 2.21 | 22 / 170 | 17% | 0.94 | 80 / 459 |
bladder | 19% | 1.95 | 4 / 21 | 5% | 0.18 | 26 / 504 |
lung | 16% | 1.86 | 90 / 578 | 5% | 0.18 | 52 / 1155 |
tonsil | 0% | 0 | 0 / 0 | 20% | 4.08 | 9 / 45 |
skin | 12% | 1.79 | 216 / 1809 | 5% | 0.26 | 23 / 472 |
adipose | 16% | 2.14 | 196 / 1204 | 0% | 0 | 0 / 0 |
intestine | 8% | 0.74 | 79 / 966 | 4% | 0.11 | 22 / 527 |
ovary | 9% | 0.54 | 16 / 180 | 2% | 0.04 | 10 / 430 |
breast | 3% | 0.39 | 12 / 459 | 8% | 0.53 | 84 / 1118 |
prostate | 10% | 1.66 | 24 / 245 | 0% | 0 | 0 / 502 |
pancreas | 2% | 0.06 | 5 / 328 | 4% | 0.07 | 7 / 178 |
adrenal gland | 3% | 0.23 | 9 / 258 | 0% | 0 | 0 / 230 |
blood vessel | 2% | 0.10 | 27 / 1335 | 0% | 0 | 0 / 0 |
heart | 2% | 0.14 | 15 / 861 | 0% | 0 | 0 / 0 |
muscle | 1% | 0.08 | 11 / 803 | 0% | 0 | 0 / 0 |
brain | 1% | 0.07 | 32 / 2642 | 0% | 0.00 | 1 / 705 |
abdomen | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
bone marrow | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
diaphragm | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
eye | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 80 |
gingiva | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
liver | 0% | 0 | 0 / 226 | 0% | 0 | 0 / 406 |
nasal cavity | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
nasopharynx | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
nose | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
placenta | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
spinal column | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
ureter | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 1 |
GO_0007165 | Biological process | signal transduction |
GO_0006915 | Biological process | apoptotic process |
GO_0006955 | Biological process | immune response |
GO_0010989 | Biological process | negative regulation of low-density lipoprotein particle clearance |
GO_2001237 | Biological process | negative regulation of extrinsic apoptotic signaling pathway |
GO_2001244 | Biological process | positive regulation of intrinsic apoptotic signaling pathway |
GO_0072593 | Biological process | reactive oxygen species metabolic process |
GO_0005615 | Cellular component | extracellular space |
GO_0005576 | Cellular component | extracellular region |
GO_0005125 | Molecular function | cytokine activity |
Gene name | IL19 |
Protein name | Interleukin-19 (IL-19) (Melanoma differentiation-associated protein-like protein) (NG.1) |
Synonyms | ZMDA1 |
Description | FUNCTION: Cytokine that functions as an anti-inflammatory and proangiogenic factor . Polarizes adaptive immunity to an anti-inflammatory phenotype through induction of T-helper 2 responses by both down-regulation of IFN-gamma and up-regulation of IL4 and IL13 . Produced by osteocytes, stimulates granulopoiesis and neutrophil formation (By similarity). Exerts its biological effect through a receptor complex consisting of a heterodimer of IL20RA and IL20RB . In turn, activates the Janus kinase (JAK) and signal transducer and activator of transcription (STAT) pathway, and importantly, STAT3 . . |
Accessions | ENST00000656872.2 [Q9UHD0-1] ENST00000340758.7 [Q9UHD0-1] ENST00000270218.10 [Q9UHD0-1] Q9UHD0 ENST00000659997.3 [Q9UHD0-1] |